Proteomic Biomarker Discovery in Breast Cancer: Advances, Challenges, and Translational Prospects
This review critically evaluates current proteomic technologies and proteomics‐derived biomarker candidates in breast cancer, distinguishes discovery‐level findings from clinically validated evidence, and discusses the major methodological, regulatory, and implementation barriers that continue to limit translation into...